JSW:GPWJastrzebska Spolka Weglowa S.A. Analysis
Data as of 2026-03-15 - not real-time
₹15,598.75
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
JSW Holdings is trading at ₹15,598.75, well below its 20‑day SMA of ₹16,774 and 50‑day SMA of ₹17,508, indicating a bearish price bias. The RSI of 34 suggests the stock is oversold, while the MACD histogram remains negative, reinforcing short‑term downside momentum. However, the price‑to‑book ratio of 0.52 (well under 1) points to a valuation cushion relative to its book value of ₹30,255 per share.
The trailing PE of 122 vastly exceeds the industry average of 29, flagging significant earnings overvaluation, and the beta near zero signals minimal market‑wide volatility exposure. Volatility over the past 30 days sits above 32%, and volume is trending higher, yet liquidity remains modest given the market cap of ₹173 bn. Combined, these metrics suggest a cautious stance: potential short‑term rebound from support at ₹15,536, but limited upside without a clear earnings catalyst.
The trailing PE of 122 vastly exceeds the industry average of 29, flagging significant earnings overvaluation, and the beta near zero signals minimal market‑wide volatility exposure. Volatility over the past 30 days sits above 32%, and volume is trending higher, yet liquidity remains modest given the market cap of ₹173 bn. Combined, these metrics suggest a cautious stance: potential short‑term rebound from support at ₹15,536, but limited upside without a clear earnings catalyst.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 4/10
Key Factors
- Price below short‑term moving averages
- Oversold RSI but bearish MACD
- Proximity to technical support level
Medium Term
1–3 yearsCautious
Model confidence: 6/10
Key Factors
- Trailing PE far above industry norm
- Persistent bearish trend direction
- High 30‑day volatility without earnings improvement
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Price‑to‑book ratio below 1 indicating value floor
- Low beta reducing systematic risk
- Regulatory environment for NBFCs remains uncertain
Key Metrics & Analysis
Financial Health
Revenue Growth11.80%
Profit Margin81.26%
P/E Ratio122.0
P/B Ratio0.5
Industry P/E29.1
Technical Analysis
TrendBearish
RSI34.0
Support₹15,535.90
Resistance₹18,701.00
MA 20₹16,773.53
MA 50₹17,508.31
MA 200₹19,009.03
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
GradeOvervalued
TypeBlend
Risk Assessment
Beta0.09
Volatility32.46%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.